
Xoneklear S 1000mg/500mg Injection
Marketer
Mediklear Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Xoneklear S 1000mg/500mg Injection
Combiflox S 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation and infection spread. Administration must be overseen by a physician. Consistent adherence to the prescribed schedule is crucial; complete the entire course, even with symptom improvement. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While it usually doesn't impair driving, avoid driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration are vital for optimal recovery. Your doctor might order blood tests and other diagnostics to monitor treatment response.
Uses of Xoneklear S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Xoneklear S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xoneklear S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xoneklear S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Xoneklear S 1000mg/500mg Injection works:
Xoneklear S, a 1000mg/500mg injectable formulation, unites Ceftriaxone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Xoneklear S 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Xoneklear S (1000mg/500mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administration of Xoneklear S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xoneklear S 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xoneklear S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Xoneklear S 1000mg/500mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Dosage alteration for Xoneklear S 1000mg/500mg Injection isn't suggested for individuals with mild or moderate liver dysfunction.
What if you forget to take Xoneklear S 1000mg/500mg Injection :
Should you inadvertently skip a dose of Xoneklear S 1000mg/500mg Injection, seek medical advice from your physician.
Facts to Know About Xoneklear S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
